-
公开(公告)号：US20130288302A1
公开(公告)日：2013-10-31
申请号：US13788246
申请日：2013-03-07
Applicant: Genentech, Inc.
Inventor： Sherman Fong , Mark S. Dennis
IPC: C07K16/28
CPC classification number: C07K16/2839 , A61K2039/505 , C07K16/18 , C07K16/2827 , C07K2317/14 , C07K2317/24 , C07K2317/41 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
-
公开(公告)号：US20180291104A1
公开(公告)日：2018-10-11
申请号：US15721227
申请日：2017-09-29
Applicant: Genentech, Inc.
Inventor： Sherman Fong , Mark Dennis
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
-
公开(公告)号：US20170044261A1
公开(公告)日：2017-02-16
申请号：US15079804
申请日：2016-03-24
Applicant: Genentech, Inc.
Inventor： Sherman Fong , Mark S. Dennis
IPC: C07K16/28
CPC classification number: C07K16/2839 , A61K2039/505 , C07K16/18 , C07K16/2827 , C07K2317/14 , C07K2317/24 , C07K2317/41 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
Abstract translation: 本发明提供了治疗性抗-β7抗体，组合物和使用这些抗体的方法。
-
Patent Agency Ranking
公开(公告)号：US20150197560A1
公开(公告)日：2015-07-16
申请号：US14454884
申请日：2014-08-08
Applicant: GENENTECH, INC.
Inventor： Sherman Fong , Mark S. Dennis
IPC: C07K16/18
CPC classification number: C07K16/2839 , A61K2039/505 , C07K16/18 , C07K16/2827 , C07K2317/14 , C07K2317/24 , C07K2317/41 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
-
5.发明申请NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF 审中-公开IL-17同种异体多核苷酸编码受体的核酸及其用途公开(公告)号：US20140323706A1
公开(公告)日：2014-10-30
申请号：US13850095
申请日：2013-03-25
Applicant: GENENTECH, INC.
Inventor： Jian Chen , Ellen Filvaroff , Sherman Fong , Audrey Goddard , Paul Godowski , Christopher Grimaldi , Austin Gurney , Hanzhong Li , Kenneth Hillan , Daniel Tumas , Menno VanLookeren , Richard Vandlen , Colin Watanabe , P. Mickey Williams , William I. Wood , Daniel Yansura
IPC: C07K14/705
CPC classification number: C07K14/705 , A61K38/00 , C07K14/54 , G01N33/57415 , G01N33/57419 , G01N33/57423 , G01N2500/04
Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Abstract translation: 本发明涉及新型多肽和编码那些多肽的核酸分子。 本文还提供了包含那些核酸序列的载体和宿主细胞，包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子，与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。
-
公开(公告)号：US20200048354A1
公开(公告)日：2020-02-13
申请号：US16358874
申请日：2019-03-20
Applicant: Genentech, Inc.
Inventor： Sherman Fong , Mark Dennis
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
-
公开(公告)号：US20170210807A1
公开(公告)日：2017-07-27
申请号：US15485159
申请日：2017-04-11
Applicant: Genentech, Inc.
Inventor： Sherman Fong , Mark Dennis
IPC: C07K16/28
CPC classification number: C07K16/2839 , A61K2039/505 , C07K16/18 , C07K16/2827 , C07K2317/14 , C07K2317/24 , C07K2317/41 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
-
公开(公告)号：US20170042967A1
公开(公告)日：2017-02-16
申请号：US15065777
申请日：2016-03-09
Applicant: GENENTECH, INC.
Inventor： Avi Ashkenazi , Karim Yussef Helmy , Sherman Fong , Audrey Goddard , Austin L. Gurney , Kenneth James Katschke, Jr. , Menno Van Lookeren , William I. Wood
IPC: A61K38/17 , C07K14/705
CPC classification number: A61K38/177 , A61K38/17 , A61K38/1709 , A61K2039/505 , C07K14/705 , C07K16/28 , C07K2317/77 , C07K2319/30 , Y02A50/463 , A61K2300/00
Abstract: The present invention concerns a recently discovered macrophage specific receptor, CRIg, and its use in the treatment of complement-associated disorders.
Abstract translation: 本发明涉及最近发现的巨噬细胞特异性受体CRIg及其在补体相关疾病的治疗中的应用。
-
-
-
-
-
-
-
Search Results
8
records
(took 0.03 seconds)
